Skip to main content
. 2007 Feb 2;7:2. doi: 10.1186/1472-6904-7-2

Table 3.

Adverse events [n (%)] occurring in ≥ 10% of subjects in any treatment group

Event Treatment Regimen A (fasting; n = 28) Treatment Regimen B (fed; n = 29) Treatment Regimen C (fasting with naltrexone block; n = 27)
Nausea 6 (21.4) 9 (31.0) 7 (25.9)
Asthenia 6 (21.4) 8 (27.6) 7 (25.9)
Dizziness 8 (28.6) 5 (17.2) 3 (11.1)
Pruritus 2 (7.1) 4 (13.8) 9 (33.3)
Headache 6 (21.4) 3 (10.3) 4 (14.8)
Vomiting 2 (7.1) 3 (10.3) 5 (18.5)